CorMedix (CRMD) FCF Margin (2015 - 2025)

CorMedix (CRMD) reported FCF Margin of 72.11% for Q4 2025, up 9013.0% on a YoY basis from 0.79% in Q4 2024, and up 147.74% sequentially from 29.11% in Q3 2025.

CorMedix (CRMD) FCF Margin (2015 - 2025) Analysis & Trends

CorMedix (CRMD) has 10 years of FCF Margin data on file, last reported at 72.11% in Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 9013.0% year-over-year to 72.11%; the trailing twelve-month figure through Dec 2025 stood at 55.43% (up 17205.0% YoY), and the FY2025 full-year result was 55.43%, up 17213.0% from the prior year.
  • FCF Margin grew to 72.11% in Q4 2025, from 29.11% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 75.42% in Q2 2025 to a low of 89069.3% in Q3 2022.
  • A 4-year average of 19961.88% and a median of 7595.53% in 2021 frame the typical range for FCF Margin.
  • Peak annual rise in FCF Margin reached 1206455 bps in 2022, while the deepest fall reached 8078407 bps in 2022.
  • Tracing CRMD's FCF Margin over 4 years: stood at 11522.1% in 2021, then slumped by 84 bps to 21155.46% in 2022, then surged by 100 bps to 18.02% in 2024, then surged by 500 bps to 72.11% in 2025.
  • Business Quant data shows CRMD's FCF Margin at 72.11% in Q4 2025, 29.11% in Q3 2025, and 75.42% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn 72.11%

Historic Data

Download Data
DateValue
Dec 31, 2025 72.11%
Sep 30, 2025 29.11%
Jun 30, 2025 75.42%
Mar 31, 2025 50.47%
Dec 31, 2024 -18.02%
Sep 30, 2024 -119.23%
Jun 30, 2024 -1,745.98%
Dec 31, 2022 -21,155.46%
Sep 30, 2022 -89,069.30%
Jun 30, 2022 -25,746.85%
Mar 31, 2022 -88,379.60%
Dec 31, 2021 -11,522.10%
Sep 30, 2021 -16,491.83%
Jun 30, 2021 -37,811.40%
Mar 31, 2021 -7,595.53%
Dec 31, 2020 -10,788.26%
Sep 30, 2020 -7,884.82%
Jun 30, 2020 -4,612.33%
Mar 31, 2020 -10,771.66%
Dec 31, 2019 -15,716.10%